Literature DB >> 3663263

Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis.

R I Sperling1, M Weinblatt, J L Robin, J Ravalese, R L Hoover, F House, J S Coblyn, P A Fraser, B W Spur, D R Robinson.   

Abstract

Twelve patients with active rheumatoid arthritis supplemented their usual diet with 20 gm of Max-EPA fish oil, daily, for 6 weeks. Following this supplementation, the ratio of arachidonic acid to eicosapentaenoic acid in the patients' neutrophil cellular lipids decreased from 81:1 to 2.7:1, and the mean generation of leukotriene B4 (with calcium ionophore stimulation) significantly declined by 33%. The mean neutrophil chemotaxis to both leukotriene B4 and FMLP significantly increased toward the normal range at week 6. The generation of 5-lipoxygenase products by calcium ionophore-stimulated monocytes was not significantly suppressed, but a significant decline (37%) in platelet-activating factor generation was noted at week 6. The modulation of these measures of leukocyte inflammatory potential suggests that fish oil supplementation may have an antiinflammatory effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3663263     DOI: 10.1002/art.1780300905

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  31 in total

1.  Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.

Authors:  R H Lawrence; T C Sorrelli
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

2.  Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial.

Authors:  A B Hawthorne; T K Daneshmend; C J Hawkey; A Belluzzi; S J Everitt; G K Holmes; C Malkinson; M Z Shaheen; J E Willars
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

Review 3.  Molecular mechanism of methotrexate action in inflammation.

Authors:  B N Cronstein
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

4.  Dietary fish oil blocks the microcirculatory manifestations of ischemia-reperfusion injury in striated muscle in hamsters.

Authors:  H A Lehr; C Hübner; D Nolte; A Kohlschütter; K Messmer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

Review 5.  Fish oil and rheumatoid arthritis: does a herring a day keep rheumatologists away?

Authors:  J Belch
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

Review 6.  Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids.

Authors:  J M Kremer
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

7.  Docosahexaenoic acid (DHA) and docosapentaenoic acid (DPAn-6) algal oils reduce inflammatory mediators in human peripheral mononuclear cells in vitro and paw edema in vivo.

Authors:  Julie M Nauroth; Ying Chun Liu; Mary Van Elswyk; Rebecca Bell; Eileen Bailey Hall; Gloria Chung; Linda M Arterburn
Journal:  Lipids       Date:  2010-04-04       Impact factor: 1.880

Review 8.  An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.

Authors:  Silvia Lorente-Cebrián; André G V Costa; Santiago Navas-Carretero; María Zabala; Laura M Laiglesia; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  J Physiol Biochem       Date:  2015-03-11       Impact factor: 4.158

9.  Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed.

Authors:  D C Nordström; V E Honkanen; Y Nasu; E Antila; C Friman; Y T Konttinen
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

10.  Inhibition of human neutrophil leukotriene B4 synthesis in essential fatty acid deficiency: role of leukotriene A hydrolase.

Authors:  L G Cleland; M J James; S M Proudman; M A Neumann; R A Gibson
Journal:  Lipids       Date:  1994-03       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.